08/25/2025
7:59 PM | Rhythm Pharmaceuticals (Issuer)
Shulman Joseph (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/21/2025
3:45 PM | Rhythm Pharmaceuticals (Subject)
Shulman Joseph (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/14/2025
5:47 PM | German Christopher Paul (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/14/2025
5:48 PM | Rhythm Pharmaceuticals (Issuer)
Smith Hunter C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/14/2025
5:04 PM | RA CAPITAL MANAGEMENT, L.P. (Filed by)
Rhythm Pharmaceuticals (Subject)
| Form SCHEDULE 13G/A | |
08/14/2025
12:28 PM | PRIMECAP MANAGEMENT CO/CA/ (Filed by)
Rhythm Pharmaceuticals (Subject)
| Form SCHEDULE 13G/A | |
08/13/2025
5:32 PM | Rhythm Pharmaceuticals (Issuer)
Shulman Joseph (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/11/2025
3:22 PM | Rhythm Pharmaceuticals (Subject)
Shulman Joseph (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/05/2025
6:05 AM | Rhythm Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/29/2025
5:56 PM | Cramer Pamela J. (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/11/2025
3:30 PM | Cramer Pamela J. (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for RYTM and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Rhythm Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. |
07/11/2025
3:30 PM | German Christopher Paul (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/11/2025
3:30 PM | Rhythm Pharmaceuticals (Issuer)
Shulman Joseph (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/11/2025
3:31 PM | Rhythm Pharmaceuticals (Issuer)
Smith Hunter C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/11/2025
6:00 AM | Rhythm Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/09/2025
4:06 PM | Rhythm Pharmaceuticals (Filer)
| Form 424B5 | |
07/09/2025
3:39 PM | Rhythm Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/08/2025
3:30 PM | Rhythm Pharmaceuticals (Issuer)
Smith Hunter C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2025
4:12 PM | Garfield Alastair (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2025
3:55 PM | Rhythm Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/26/2025
3:56 PM | Bedrosian Camille L (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2025
3:41 PM | JEAN CHRISTOPHE (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2025
3:45 PM | Mathers Edward T (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2025
3:45 PM | GOOD JENNIFER L (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2025
3:30 PM | MCGIRR DAVID W J (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2025
3:33 PM | Rhythm Pharmaceuticals (Issuer)
TETRAULT LYNN A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2025
3:37 PM | Arbuckle Stuart A (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2025
3:48 PM | Rhythm Pharmaceuticals (Issuer)
TETRAULT LYNN A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2025
3:49 PM | MCGIRR DAVID W J (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2025
3:51 PM | Arbuckle Stuart A (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2025
3:52 PM | Bedrosian Camille L (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2025
3:53 PM | GOOD JENNIFER L (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2025
3:53 PM | JEAN CHRISTOPHE (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2025
3:50 PM | German Christopher Paul (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2025
3:45 PM | Cramer Pamela J. (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2025
3:21 PM | German Christopher Paul (Reporting)
Rhythm Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/06/2025
3:25 PM | Cramer Pamela J. (Reporting)
Rhythm Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/05/2025
3:16 PM | Meeker David P (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2025
3:16 PM | MCGIRR DAVID W J (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/03/2025
3:27 PM | MCGIRR DAVID W J (Reporting)
Rhythm Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/30/2025
3:35 PM | Rhythm Pharmaceuticals (Subject)
Smith Hunter C (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Trump’s national nightmare is here (Ad) Porter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger the biggest forced rotation of capital since World War II.
They reveal why Trump is mobilizing America’s tech giants… and name the two stocks most likely to soar as trillions shift behind the scenes. Watch the National Emergency broadcast here |
05/15/2025
5:20 PM | PERCEPTIVE ADVISORS LLC (Filed by)
Rhythm Pharmaceuticals (Subject)
| Form SCHEDULE 13G/A | |
05/07/2025
6:01 AM | Rhythm Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/24/2025
7:59 AM | BlackRock, Inc. (Filed by)
Rhythm Pharmaceuticals (Subject)
| Form SCHEDULE 13G/A | |
04/16/2025
3:30 PM | Mazabraud Yann (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/10/2025
4:16 PM | Mazabraud Yann (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/10/2025
4:17 PM | Cramer Pamela J. (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/07/2025
6:01 AM | Rhythm Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/24/2025
4:47 PM | German Christopher Paul (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/20/2025
3:05 PM | Rhythm Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/18/2025
8:16 PM | Mazabraud Yann (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/14/2025
3:21 PM | Mazabraud Yann (Reporting)
Rhythm Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/28/2025
7:19 AM | Rhythm Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/28/2025
7:21 AM | Rhythm Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/26/2025
6:02 AM | Rhythm Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/19/2025
8:45 PM | German Christopher Paul (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/19/2025
8:46 PM | Lee Jennifer Kayden (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/19/2025
8:47 PM | Mazabraud Yann (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/19/2025
8:48 PM | Meeker David P (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/19/2025
8:49 PM | Rhythm Pharmaceuticals (Issuer)
Shulman Joseph (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/19/2025
8:50 PM | Rhythm Pharmaceuticals (Issuer)
Smith Hunter C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/19/2025
8:44 PM | Garfield Alastair (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/19/2025
8:43 PM | Cramer Pamela J. (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2025
5:36 PM | PRIMECAP MANAGEMENT CO/CA/ (Filed by)
Rhythm Pharmaceuticals (Subject)
| Form SCHEDULE 13G/A | |
02/11/2025
8:46 PM | Lee Jennifer Kayden (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/11/2025
8:47 PM | Rhythm Pharmaceuticals (Issuer)
Shulman Joseph (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/11/2025
8:44 PM | Rhythm Pharmaceuticals (Issuer)
Smith Hunter C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/11/2025
8:45 PM | Cramer Pamela J. (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/10/2025
4:30 PM | GOLDMAN SACHS GROUP INC (Filed by)
GOLDMAN SACHS GROUP INC (Filed by)
Rhythm Pharmaceuticals (Subject)
| Form SCHEDULE 13G/A | |
02/07/2025
4:05 PM | Lee Jennifer Kayden (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2025
3:20 PM | Lee Jennifer Kayden (Reporting)
Rhythm Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/04/2025
8:27 PM | Rhythm Pharmaceuticals (Issuer)
Smith Hunter C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/04/2025
8:22 PM | Cramer Pamela J. (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/04/2025
8:23 PM | Lee Jennifer Kayden (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/04/2025
8:25 PM | Meeker David P (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/04/2025
8:26 PM | Rhythm Pharmaceuticals (Issuer)
Shulman Joseph (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/10/2025
6:17 AM | Rhythm Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
8:50 PM | PERCEPTIVE ADVISORS LLC (Filed by)
Rhythm Pharmaceuticals (Subject)
| Form SC 13G | |
11/14/2024
4:46 PM | RA CAPITAL MANAGEMENT, L.P. (Filed by)
Rhythm Pharmaceuticals (Subject)
| Form SC 13G/A | |
11/13/2024
8:01 PM | Rhythm Pharmaceuticals (Issuer)
Shulman Joseph (Reporting)
| Form 4/A | |
11/13/2024
8:02 PM | Rhythm Pharmaceuticals (Issuer)
Shulman Joseph (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/13/2024
8:04 PM | Lee Jennifer Kayden (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/06/2024
4:07 PM | Cramer Pamela J. (Reporting)
Rhythm Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/06/2024
7:20 AM | Rhythm Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/05/2024
3:02 PM | Rhythm Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/19/2024
3:49 PM | Rhythm Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/19/2024
3:30 PM | GOOD JENNIFER L (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/17/2024
3:42 PM | GOOD JENNIFER L (Reporting)
Rhythm Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/11/2024
3:30 PM | GOOD JENNIFER L (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/11/2024
3:31 PM | Rhythm Pharmaceuticals (Issuer)
TETRAULT LYNN A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/11/2024
3:32 PM | Cramer Pamela J. (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off (Ad) Right now, we’re witnessing a monumental shift in the world. Our No. 1 AI Pick is currently trading for pennies on the dollar compared to Nividia. |
09/09/2024
3:31 PM | GOOD JENNIFER L (Reporting)
Rhythm Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/28/2024
3:30 PM | GOOD JENNIFER L (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/28/2024
3:31 PM | Rhythm Pharmaceuticals (Issuer)
TETRAULT LYNN A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/28/2024
3:31 PM | Cramer Pamela J. (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
MarketBeat All Access